Biblio

Export 496 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is N  [Clear All Filters]
2022
N. Altomari, Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Di Lorenzo, R., Frangipane, F., Maletta, R., Puccio, G., and Bruni, A. Cecilia, A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
N. Baazaoui and Iqbal, K., COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences., J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
Z. Liu, Paek, E. Jin, Yoon, S. On, Casenhiser, D., Zhou, W., and Zhao, X., Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts., J Alzheimers Dis, vol. 86, no. 3, pp. 1385-1398, 2022.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
X. Sun, Suo, X., Xia, X., Yu, C., and Dou, Y., Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
F. Fan, Liu, H., Shi, X., Ai, Y., Liu, Q., and Cheng, Y., The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review., J Alzheimers Dis, vol. 85, no. 3, pp. 1195-1204, 2022.
D. Cutuli, Landolfo, E., Petrosini, L., and Gelfo, F., Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders., J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
D. Cutuli, Landolfo, E., Petrosini, L., and Gelfo, F., Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders., J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
X. Wang, Li, F., Gao, Q., Jiang, Z., Abudusaimaiti, X., Yao, J., and Zhu, H., Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis., J Alzheimers Dis, vol. 87, no. 1, pp. 285-304, 2022.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
L. Clare, Martyr, A., Gamble, L. D., Pentecost, C., Collins, R., Dawson, E., Hunt, A., Parker, S., Allan, L., Burns, A., Hillman, A., Litherland, R., Quinn, C., Matthews, F. E., and Victor, C., Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort., J Alzheimers Dis, vol. 85, no. 2, pp. 925-940, 2022.
S. Preethy, Ranganathan, N., Raghavan, K., Dedeepiya, V. Devaprasad, Ikewaki, N., and Abraham, S. J. K., Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders., J Alzheimers Dis, vol. 87, no. 4, pp. 1451-1460, 2022.
J. Ning, Huang, S. - Y., Chen, S. - D., Zhang, Y. - R., Huang, Y. - Y., and Yu, J. - T., Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study., J Alzheimers Dis, vol. 87, no. 1, pp. 211-222, 2022.
V. Panzarella, Mauceri, R., Baschi, R., Maniscalco, L., Campisi, G., and Monastero, R., Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project., J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
A. Crestini, Santilli, F., Martellucci, S., Carbone, E., Sorice, M., Piscopo, P., and Mattei, V., Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 503-518, 2022.
A. Crestini, Santilli, F., Martellucci, S., Carbone, E., Sorice, M., Piscopo, P., and Mattei, V., Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 503-518, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
K. Metsla, Kirss, S., Laks, K., Sildnik, G., Palgi, M., Palumaa, T., Tõugu, V., and Palumaa, P., α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.

Pages